JPMorgan Chase & Co. Sells 373,896 Shares of Encompass Health Corporation $EHC

JPMorgan Chase & Co. reduced its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 21.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,339,948 shares of the company’s stock after selling 373,896 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.33% of Encompass Health worth $164,318,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Avantax Advisory Services Inc. raised its stake in shares of Encompass Health by 2.3% during the 1st quarter. Avantax Advisory Services Inc. now owns 10,054 shares of the company’s stock worth $1,018,000 after purchasing an additional 223 shares during the period. Cetera Investment Advisers boosted its stake in Encompass Health by 9.1% in the first quarter. Cetera Investment Advisers now owns 15,834 shares of the company’s stock valued at $1,604,000 after acquiring an additional 1,319 shares during the last quarter. HB Wealth Management LLC purchased a new position in Encompass Health in the first quarter valued at about $339,000. LPL Financial LLC grew its position in shares of Encompass Health by 30.8% during the 1st quarter. LPL Financial LLC now owns 46,525 shares of the company’s stock valued at $4,712,000 after acquiring an additional 10,967 shares during the period. Finally, Vestcor Inc increased its stake in shares of Encompass Health by 23.0% during the 1st quarter. Vestcor Inc now owns 74,737 shares of the company’s stock worth $7,569,000 after purchasing an additional 13,962 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. UBS Group increased their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Trading Up 0.1%

Shares of EHC opened at $116.36 on Thursday. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.99. The stock has a market cap of $11.71 billion, a PE ratio of 22.00, a P/E/G ratio of 2.20 and a beta of 0.91. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The business’s 50-day moving average price is $120.80 and its 200-day moving average price is $119.53.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The business had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.